Abstract
Cancer of the pancreas is currently the fifth leading cause of cancer related deaths with a five year survival of less than 1% In the United States (1). It is one of the most difficult cancers to treat, since it is hard to detect in the early stages. The patients remain asymptomatic until late in the course of the disease. An excellent review of pancreatic carcinoma has appeared (2). Despite the progress made in our understanding of the biology of this cancer (3), the final outcome for this disease has remained extremely poor. Conventional chemotherapeutic agents have not been very effective for human pancreatic adenocarcinoma (4). Use of intratumoral chemotherapy in combination with monoclonal antibodies have been reported to produce better response rate and also reduced toxicity (5,6). Smith and colleagues (7) have recently shown that an injectable gel with a sustained release profile can inhibit tumor growth in vivo in human pancreatic cancer xenografts. This was demonstrated in nude mice with BxPC-3 xenografts using fluorouracil, cisplatin, and doxorubicin with a consequent size reduction of the tumors between 72% and 79%, compared to the controls at day 28 after the first treatment. Although these figures are impressive, by any standard, no cure was reported.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Keller, J. W. and Peacock, J. L. (1993) In Clinical Oncology (Rubin, P., ed.), W. B. Saunders, Philadelphia, p. 597.
Warshaw, A. L. and Castillo, C. F-D. (1992) Pancreatic carcinoma. N. Engl. J. Med. 326, 455–465.
Poston, G. J. (1991) Biology of pancreatic cancer. Gut 32, 800–812.
Wils, J. A. (1991) Chemotherapy in pancreatic cancer: a rational pursuit. Anticancer Drugs 2, 3–10.
Otsuji, E., Yamaguchi, T., Yamaoka, N., Kitamura, K., Yamaguchi, N., and Takahashi, T. (1993) Intratumoral administration of neocarzinostatin conjugated to monoclonal antibody A7 in a model of pancreatic cancer. J. Surg. Oncol. 53, 215–219.
Otsuji, E., Yamaguchi, T., Tsuruta, H., Yata, Y., Nishi, H., Okamoto, K., Taniguchi, K., Kato, M., Kotani, T., Kitamura, K., and Takahashi, T. (1995) The effect of intravenous and intra-tumoral chemotherapy using a monoclonal antibody-drug conjugate in a xenograft model of pancreatic cancer. Eur. J. Surg. Oncol. 21, 61–65.
Smith, J. P., Stock, E., Orenberg, E. K., Yu, N. Y., Kanekal, S., and Brown, D. M. (1995) Intratumoral chemotherapy with a sustained release drug delivery system inhibits growth of human pancreatic xenografts. Anticancer Drugs. 6, 717–726.
Dev, S. B. and Hofmann, G. A. (1994) Electrochemotherapy: A novel method of cancer treatment. Cancer Treat. Rev. 20, 105–115.
Hofmann, G. A., Dev, S. B., and Nanda, G. S. (1996) Electrochemotherapy: Transition from laboratory to the clinic. IEEE Eng. Med. Biol. 15, 124-132.
Jaroszeski M. J., Gilbert, R. A., and Heller, R. (1997) In vivo antitumor effects of electrochemotherapy in a hepatoma model. Biochim. Biophys. Acta 1334, 15–18.
Dev, S. B., Nanda, G. S., An, Z., Wang, X., Hoffman, R. M., and Hofmann, G. A. (1997) An effective electroporation therapy of human pancreatic tumors implanted in nude mice. Drug Deliv. 4, 293–299.
Nanda, G. S., Sun, F. X., Hofmann, G. A., Hoffman, R. M., and Dev, S. B. (1998) Electroporation therapy of human larynx tumors HEp-2 implanted in nude mice. Anticancer Res. 18, 999–1004.
Nanda, G. S., Sun F. X., Hofmann G. A. Hoffman R. M. and Dev, S. B. (1998) Electroporation enhances therapeutic efficacy of anticancer drugs: Treatment of human pancreatic tumor in animal model. Anticancer Res. 18, 1361–1366.
Mir, L. M., Belehradek, M., Domenge, C., Orlowski, S., Poddevin, B., Belehradek, J. J., Schwaab, G., Luboinski, B., and Paoletti, C. (1991) Electrochemotherapy, a novel antitumor treatment: First clinical trial. C. R. Acad. Sci. III 313, 613–618.
Heller, R., Jaroszeski, M. J., Glass, L. F., Messina, J. L., and Rapaport, D. P. (1996) Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 77, 964–966.
Hofmann, G. A., Dev, S. B., Dimmer, S., and Nanda, G. S. (1998) Electroporation therapy of head and neck cancer. IEEE Trans. Tech. Biomed. Eng. 46, 752–759.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Dev, S.B., Hofmann, G.A., Nanda, G.S. (2000). Treatment of Human Pancreatic Tumors Xenografted in Nude Mice by Chemotherapy Combined with Pulsed Electric Fields. In: Jaroszeski, M.J., Heller, R., Gilbert, R. (eds) Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery. Methods in Molecular Medicine, vol 37. Humana Press. https://doi.org/10.1385/1-59259-080-2:277
Download citation
DOI: https://doi.org/10.1385/1-59259-080-2:277
Publisher Name: Humana Press
Print ISBN: 978-0-89603-606-2
Online ISBN: 978-1-59259-080-3
eBook Packages: Springer Protocols